Initiating primary thromboprophylaxis in an ambulatory cancer patient receiving chemotherapy. CYP3A4, cytochrome P450 3A4; P-gp, P-glycoprotein. *Characteristics associated with high bleeding risk to consider: previous major bleeding, known hemorrhagic lesion, active bleeding, severe renal dysfunction, severe thrombocytopenia, and bleeding diathesis.